Breast Cancer Trial, By Invitation NCT07409298 Sponsor: Tianjin Medical University Cancer Institute and Hospital Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, By Invitation

NCT07409298
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Women aged 18 or older, whether or not they have gone through menopause.
  • People who have been diagnosed with a specific type of breast cancer that is hormone receptor-positive and HER2-negative (HR+/HER2-).
  • People who are currently receiving, or are planned to receive, a type of cancer treatment called a CDK4/6 inhibitor.
  • People whose general health and ability to carry out daily activities falls within an acceptable range, as measured by a standard medical scale (confirm with trial site).
  • People with no history of serious mental health conditions such as bipolar disorder or schizophrenia.
  • People who are in a stable enough mental state to understand and take part in psychological support activities.
  • People who are already following a rehabilitation plan that includes exercise and physical therapy.
  • People who are willing to sign a consent form agreeing to take part in the trial.
  • People who are able to use a smartphone or computer to complete activities online.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with serious health complications — such as heart disease or severe liver or kidney problems — that would make it unsafe to receive CDK4/6 inhibitor treatment.
  • People with a history of severe mental illness — such as severe depression, bipolar disorder, or schizophrenia — that would make it difficult to complete self-assessment tasks.
  • People who have had another type of cancer in the past 5 years (some exceptions may apply for certain cancers that have been fully treated — confirm with trial site).
  • People who are currently pregnant or breastfeeding.
  • People of childbearing potential whose pregnancy test result is positive at the start of the trial.
  • People who are unable to adapt to or tolerate the way the AI virtual doctor delivers its support (confirm with trial site).
  • People who have any other condition that the trial doctor considers unsuitable for participation.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
5 July 2025
Est. completion
24 May 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Depression; anxiety

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov